Molecular modelling of human microsomal epoxide hydrolase (EH) by homology with a fungal (Aspergillus niger) EH crystal structure 0 of 1.8 A resolution:: structure-activity relationships in epoxides inhibiting EH activity

被引:11
作者
Lewis, DFV [1 ]
Lake, BG
Bird, MG
机构
[1] Univ Surrey, Sch Biomed & Mol Sci, Guildford GU2 7XH, Surrey, England
[2] BIBRA Int Ltd, Carshalton SM5 4DS, Surrey, England
[3] ExxonMobil Biomed Sci Inc, Annandale, NJ 08801 USA
关键词
D O I
10.1016/j.tiv.2004.07.001
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Homology modelling of the human microsomal epoxide hydrolase (EH) enzyme based on the fungal (Aspergillus niger) EH crystallographic template is reported. The active site lies in a well-defined, essentially hydrophobic, pocket within the overall enzyme structure. Two tyrosine residues, that are conserved in all known mammalian EH sequences, are able to form hydrogen bonds (one per tyrosine residue) with the epoxide oxygen atom on the known EH substrate, styrene oxide. There is also a small hydrophobic cleft, within the active site region, where the phenyl group of styrene oxide can bind, but this appears to be restricted such that the presence of bulky side-chains will render poor substrate status to the incoming epoxide molecule. Quantitative structure-activity relationship (QSAR) studies on a series of low molecular weight epoxides provide useful results which appear to be generally consistent with the human microsomal EH model, and thus may be used predictively for assessing the EH substrate and/or inhibitor status of untested compounds. (c) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:517 / 522
页数:6
相关论文
共 18 条
[1]   Catalytic triad of microsomal epoxide hydrolase:: replacement of Glu404 with Asp leads to a strongly increased turnover rate [J].
Arand, M ;
Müller, F ;
Mecky, A ;
Hinz, W ;
Urban, P ;
Pompon, D ;
Kellner, R ;
Oesch, F .
BIOCHEMICAL JOURNAL, 1999, 337 :37-43
[2]   Cloning and molecular characterization of a soluble epoxide hydrolase from Aspergillus niger that is related to mammalian microsomal epoxide hydrolase [J].
Arand, M ;
Hemmer, H ;
Dürk, H ;
Baratti, J ;
Archelas, A ;
Furstoss, R ;
Oesch, F .
BIOCHEMICAL JOURNAL, 1999, 344 :273-280
[3]  
Arand M., 2002, Enzyme Systems That Metabolize Drugs and Other Xenobiotics, P459, DOI DOI 10.1002/0470846305
[4]   Binding of alkylurea inhibitors to epoxide hydrolase implicates active site tyrosines in substrate activation [J].
Argiriadi, MA ;
Morisseau, C ;
Goodrow, MH ;
Dowdy, DL ;
Hammock, BD ;
Christianson, DW .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (20) :15265-15270
[5]   Detoxification of environmental mutagens and carcinogens: Structure, mechanism, and evolution of liver epoxide hydrolase [J].
Argiriadi, MA ;
Morisseau, C ;
Hammock, BD ;
Christianson, DW .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (19) :10637-10642
[6]   Kinetic and chemical mechanism of epoxide hydrolase [J].
Armstrong, RN .
DRUG METABOLISM REVIEWS, 1999, 31 (01) :71-86
[7]  
HANSCH C, 1995, EXPLORING QSAR 2
[8]   Compound lipophilicity for substrate binding to human P450s in drug metabolism [J].
Lewis, DFV ;
Jacobs, MN ;
Dickins, M .
DRUG DISCOVERY TODAY, 2004, 9 (12) :530-537
[9]   DRUG-METABOLISM IN MAN AND ITS RELATIONSHIP TO THAT IN 3 RODENT SPECIES - MONOOXYGENASE, EPOXIDE HYDROLASE, AND GLUTATHIONE S-TRANSFERASE ACTIVITIES IN SUBCELLULAR-FRACTIONS OF LUNG AND LIVER [J].
LORENZ, J ;
GLATT, HR ;
FLEISCHMANN, R ;
FERLINZ, R ;
OESCH, F .
BIOCHEMICAL MEDICINE, 1984, 32 (01) :43-56
[10]   Non-synonymous single nucleotide alterations in the microsomal epoxide hydrolase gene and their functional effects [J].
Maekawa, K ;
Itoda, M ;
Hanioka, N ;
Saito, Y ;
Murayama, N ;
Nakajima, O ;
Soyama, A ;
Ishida, S ;
Ozawa, S ;
Ando, M ;
Sawada, J .
XENOBIOTICA, 2003, 33 (03) :277-287